The usefulness of DDAVP test and GHRP-2 test in patients with Cushing's disease

The usefulness of DDAVP test and GHRP-2 test in patients with Cushing's disease - Cushing_diagnosis

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs021180039

Enrollment

Registered

2019-03-26

Start date

2018-05-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cushing's disease

Interventions

administration of DDAVP or GHRP-2

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: We invited patients with Cushing's disease.

Exclusion criteria

Exclusion criteria: Allergy to DDAVP or GHRP-2.

Design outcomes

Primary

Measure	Time frame
Serum ACTH and cortisol after administration of DDAVP or GHRP-2	—

Contacts

Public ContactShingo Murasawa

Department of Endocrinology and Metabolism

murashin@hirosaki-u.ac.jp+81-172-39-5062

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026